Navigation Links
ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium

NEW YORK, July 28, 2014 /PRNewswire/ -- David Hardison, Ph.D., vice president of health services for ConvergeHEALTH by Deloitte, has been elected chairman of the board for the Clinical Data Interchange Standards Consortium, a non-profit working to establish common protocols around the use of clinical research data, particularly as it relates to electronic health records.

Hardison will work to continue CDISC's mission of collaborating with organizations across the research and health care arena in harmonizing practices related to the acquisition, exchange, submission and archiving of clinical data and metadata.  He previously served as CDISC's chairman from 2005 to 2007.

"We are pleased to have David chair the organization once again and bring his expertise in the field to our organization," said Dr. Rebecca Kush, president and chief executive officer of CDISC. "CDISC appreciates that ConvergeHEALTH supports the open-source development of data standards and innovation to improve medical research and interoperability in many areas of health care."

Hardison said his appointment reflects Deloitte's commitment to the importance of standards-based innovation in health care.  "I have been a champion of CDISC for many years and look forward to my continued support of the organization and its vision to 'inform patient care and safety through higher quality medical research.'"

Hardison has more than 30 years of experience in the biopharmaceutical and providers sectors, including executive and board-level roles related to information technology and performance improvement. 

Hardison will speak at the CDISC Asia-Pacific/Japan Interchange 2014 on July 31 in Tokyo, an event that runs from July 28 through Aug. 1.

CDISC is a 501(c)(3) global non-profit charitable organization with more than 300 supporting member organizations from across the clinical research and health care arenas. Through the efforts of volunteers around the globe, CDISC catalyzes productive collaboration to develop industry-wide data standards enabling the harmonization of clinical data and streamlining research processes from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data. The CDISC standards and innovations can significantly decrease the time and cost of medical research and improve quality, thus contributing to the faster development of safer and more effective medical products and a learning health care system. The CDISC vision is to inform patient care and safety through higher quality medical research. For more information, visit

About ConvergeHEALTH by Deloitte
ConvergeHEALTH brings powerful, demonstrated analytics platforms and data models from Recombinant by Deloitte, advanced proprietary and open-source analytics, content and benchmarks through collaboration with industry leaders and deep experiences from Deloitte's Life Sciences and Health Care consulting practice to help our clients survive and thrive in the new paradigm of value-based, personalized medicine.  For more information, visit

As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP.  Please see for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Logo -  

SOURCE Deloitte
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer
2. DuPont Congratulates David Hula for Breaking Corn Yield World Record with Pioneer® Brand Hybrid P2088YHR in 2013 NCGA Corn Yield Contest
3. Barnet Dulaney Perkins Eye Center Regrets to Announce the Passing of David Dulaney, MD
4. Atlas Appoints David Whitaker as Operations Director
5. Dr. David R. Bassett Joins ActiGraph Scientific Advisory Board
6. David Julius Wins 2013 Dr. Paul Janssen Award for Biomedical Research
7. David Hooper Joins Evolution Marketing Research as Senior Director, Research
8. Can Science Really Get You Laid? The Shocking Truth About Dr. David Tan's "Desire System"
9. Dr. David Slaughter Launches Groundbreaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
11. David Smith Named Vice President of Operations for HealthTell
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... November 24, 2015 SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
Breaking Biology Technology:
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
Breaking Biology News(10 mins):